Market Structure: Healthcare Leads, Event Risk Builds — August 10, 2026
Healthcare leads the three-month tape while concentrated technology gains and this earnings-heavy calendar raise the bar for follow-through.
Market Outlooks
NVDA Research Note — The Proof Is August 26
NVIDIA retains exceptional growth and margins, while a fuller valuation makes the August 26 report the next decisive evidence point.
NVDA Deep Coverage Review — Analysis as of August 10, 2026
NVIDIA’s operating engine remains exceptional, but valuation, customer concentration and the August earnings window raise the burden of proof.
VRT Research Note — Backlog Meets the Conversion Test
Orders and backlog surged, but the July revenue shortfall leaves conversion as the central evidence test.
VRT Deep Coverage Review — Analysis as of August 10, 2026
Vertiv’s order surge and guidance raise strengthen the demand thesis, while backlog conversion remains the unresolved test.
Market Structure: Risk-On Tape, Neutral Macro — August 10, 2026
Broad market participation supports the advance, while a contracting July payroll reading and a 4.66% ten-year yield temper the broader macro case.
BIVI Research Note — Evidence Before Optimism
BioVie’s subgroup signal does not resolve the missing registered endpoint or the scale of pending dilution.
BIVI Deep Coverage Review — Analysis as of August 7, 2026
BIVI offers a covered 6.75% yield and fixed-rate debt, while Caesars lease uncertainty keeps tenant concentration at the center of the thesis.
Weekly Market Outlook — Week of August 10, 2026: Breadth Repaired, Inflation Sets the Bar
Broad participation has repaired the tape, but CPI arrives Wednesday with the 10-year at 4.66% and the VIX at 14.9, leaving little room for surprise.
VICI Research Note — The Tenant Concentration Test
VICI looks inexpensive on AFFO and yield, but Caesars lease talks and two-tenant concentration explain why the discount persists.